Q2 2025 Holdings
Filed 2025-08-14 | 19 holdings | $14.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Fennec Pharmaceuticals Inc(FENC) | COM | 31447P100 | $1.6M | 195,700 | 11.0% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $1.3M | 335,400 | 8.9% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $1.3M | 45,900 | 8.6% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $1.1M | 26,000 | 7.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $1.1M | 10,650 | 7.3% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $1.1M | 79,000 | 7.3% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $1.1M | 548,806 | 7.2% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $873.5K | 98,700 | 5.9% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $813.1K | 146,500 | 5.5% |
| Benitec Biopharma Inc(BNTC) | COM NEW | 08205P209 | $725.4K | 62,000 | 4.9% |
| Geron Corp(GERN) | COM | 374163103 | $705.0K | 500,000 | 4.8% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $649.1K | 46,300 | 4.4% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $561.4K | 10,600 | 3.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $515.1K | 55,000 | 3.5% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $474.1K | 57,750 | 3.2% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $320.3K | 22,700 | 2.2% |
| Mersana Therapeutics Inc | COM | 59045L106 | $190.6K | 644,000 | 1.3% |
| Seres Therapeutics Inc(MCRB) | COM | 81750R201 | $189.3K | 17,038 | 1.3% |
| Humacyte Inc(HUMA) | COM | 44486Q103 | $174.5K | 83,500 | 1.2% |